$50,000 of OMNICELL lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues pertaining to the Medicare programs treatment of automated drug compounding technology Issues pertaining to the implementation of the Drug Quality & Security Act (P.L. 113-54)"
You can find more data on corporate lobbying on Quiver Quantitative.
OMCL Insider Trading Activity
OMCL insiders have traded $OMCL stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $OMCL stock by insiders over the last 6 months:
- COREY J MANLEY (EVP&CHIEF LEGAL/ADMIN OFFICER) sold 3,880 shares for an estimated $129,010
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OMCL Hedge Fund Activity
We have seen 120 institutional investors add shares of OMCL stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CADIAN CAPITAL MANAGEMENT, LP added 1,663,060 shares (+inf%) to their portfolio in Q2 2025, for an estimated $48,893,964
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 1,450,802 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $42,653,578
- ARROWMARK COLORADO HOLDINGS LLC removed 714,746 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $21,013,532
- CITADEL ADVISORS LLC added 652,119 shares (+265.0%) to their portfolio in Q2 2025, for an estimated $19,172,298
- MILLENNIUM MANAGEMENT LLC removed 391,277 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $11,503,543
- OBERWEIS ASSET MANAGEMENT INC/ removed 333,200 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $9,796,080
- POINT72 ASSET MANAGEMENT, L.P. added 332,800 shares (+inf%) to their portfolio in Q2 2025, for an estimated $9,784,320
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
OMCL Analyst Ratings
Wall Street analysts have issued reports on $OMCL in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 08/11/2025
- Wells Fargo issued a "Overweight" rating on 07/21/2025
- Benchmark issued a "Buy" rating on 05/07/2025
To track analyst ratings and price targets for OMCL, check out Quiver Quantitative's $OMCL forecast page.
OMCL Price Targets
Multiple analysts have issued price targets for $OMCL recently. We have seen 4 analysts offer price targets for $OMCL in the last 6 months, with a median target of $40.0.
Here are some recent targets:
- Sean Wieland from Piper Sandler set a target price of $55.0 on 08/11/2025
- Stan Berenshteyn from Wells Fargo set a target price of $40.0 on 07/21/2025
- Allen Lutz from B of A Securities set a target price of $34.0 on 05/23/2025
- Bill Sutherland from Benchmark set a target price of $40.0 on 05/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
